Find Salcaprozate Sodium manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

0

JDMF

0

KDMF

0

VMF

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

0

FDA Orange Book

0

Europe

0

Canada

0

Australia

0

South Africa

0

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 203787-91-1, Snac, Sodium 8-(2-hydroxybenzamido)octanoate, E414, Salcaprozate sodium [usan], Sodium;8-[(2-hydroxybenzoyl)amino]octanoate
Molecular Formula
C15H20NNaO4
Molecular Weight
301.31  g/mol
InChI Key
UOENJXXSKABLJL-UHFFFAOYSA-M
FDA UNII
1YTW0422YU

Salcaprozate Sodium
Salcaprozate Sodium is the sodium salt form of salcaprozate, an oral absorption promoter. Salcaprozate sodium may be used as a delivery agent to promote the oral absorption of certain macromolecules with poor bioavailability such as insulin and heparin.
1 2D Structure

Salcaprozate Sodium

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
sodium;8-[(2-hydroxybenzoyl)amino]octanoate
2.1.2 InChI
InChI=1S/C15H21NO4.Na/c17-13-9-6-5-8-12(13)15(20)16-11-7-3-1-2-4-10-14(18)19;/h5-6,8-9,17H,1-4,7,10-11H2,(H,16,20)(H,18,19);/q;+1/p-1
2.1.3 InChI Key
UOENJXXSKABLJL-UHFFFAOYSA-M
2.1.4 Canonical SMILES
C1=CC=C(C(=C1)C(=O)NCCCCCCCC(=O)[O-])O.[Na+]
2.2 Other Identifiers
2.2.1 UNII
1YTW0422YU
2.3 Synonyms
2.3.1 MeSH Synonyms

1. N-(8-(2-hydroxybenzoyl)amino)caprylate

2. N-(8-(2-hydroxybenzoyl)amino)caprylate Sodium

3. N-snac

4. Snac Sodium

5. Sodium N-(8-(2-hydroxybenzoyl)amino)caprylate

2.3.2 Depositor-Supplied Synonyms

1. 203787-91-1

2. Snac

3. Sodium 8-(2-hydroxybenzamido)octanoate

4. E414

5. Salcaprozate Sodium [usan]

6. Sodium;8-[(2-hydroxybenzoyl)amino]octanoate

7. Octanoic Acid, 8-[(2-hydroxybenzoyl)amino]-, Monosodium Salt

8. Salcaprozate (sodium)

9. Sodium,8-[(2-hydroxybenzoyl)amino]octanoate

10. 1ytw0422yu

11. Sodium 8-[(2-hydroxybenzoyl)amino]octanoate

12. E-414

13. Sodium 8-((2-hydroxybenzoyl)amino)octanoate

14. Salcaprozate Sodium (usan)

15. Octanoic Acid, 8-((2-hydroxybenzoyl)amino)-, Monosodium Salt

16. Sodium Salcaprozate

17. Unii-1ytw0422yu

18. Salcaprozic Acid, Sodium Salt

19. E 414

20. Salcaprozate Sodium, 99%

21. Salcaprozic Acid Sodium Salt

22. Schembl825599

23. Chembl2107027

24. Dtxsid50174306

25. Amy24031

26. Ex-a3434

27. Mfcd00952954

28. Sodium8-(2-hydroxybenzamido)octanoate

29. Ac-31357

30. As-65676

31. P414

32. Hy-114299

33. Cs-0081977

34. Ft-0696582

35. D05787

36. I10998

37. A879665

38. Q27253228

39. Sodium 8-[(2-hydroxyphenyl)formamido]octanoate

40. Octanoic Acid, 8-[(2-hydroxybenzoyl)amino]-, Sodium Salt

41. Sodium,8-[(2-hydroxybenzoyl)amino]octanoate;sodium 8-(2-hydroxybenzamido)octanoate

2.4 Create Date
2008-02-05
3 Chemical and Physical Properties
Molecular Weight 301.31 g/mol
Molecular Formula C15H20NNaO4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count4
Rotatable Bond Count9
Exact Mass301.12900240 g/mol
Monoisotopic Mass301.12900240 g/mol
Topological Polar Surface Area89.5 Ų
Heavy Atom Count21
Formal Charge0
Complexity312
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2

API SUPPLIERS

read-more
read-more

01

LGM Pharma

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
LGM Pharma CB

02

Ami Lifesciences Private Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAMI Lifesciences is Driven by Chemistry. Powered by People.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
AMI Lifesciences

03

Zhejiang Hengkang Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothZhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.

Flag China
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Zhejiang Hengkang Pharmaceutical

04

Shanghai Minbiotech

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothShanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.

Flag China
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Shanghai Minbiotech CB

05

Biophore India Pharmaceuticals Pvt...

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Flag India
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
Biophore

06

HRV Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
HRV Global Life Sciences

07

Omgene Life Sciences Pvt. Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOmgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Omgene Company Banner

08

Honour Lab Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHonour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
Company Banner

09

Willow Birch Pharma

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWillow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Company Banner

10

Panvo Organics

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPanvo Organics: Advancing quality APIs and formulations with Halal, Kosher, US FDA, and WHO-approved manufacturing excellence.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Panvo Company Banner
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 40217

Submission : 2024-07-22

Status : Active

Type : IV

Biophore

02

Cipla Ltd

India

USDMF

arrow
Arvo
Not Confirmed

02

Cipla Ltd

India
arrow
Arvo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 39618

Submission : 2024-10-10

Status : Active

Type : IV

blank

03

Eagle Chemical Works

India

USDMF

arrow
Arvo
Not Confirmed

04

Arvo
Not Confirmed

05

Arvo
Not Confirmed

06

Arvo
Not Confirmed

07

Honour Lab Ltd

Country

USDMF

arrow
Arvo
Not Confirmed

07

Honour Lab Ltd

Country
arrow
Arvo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 40329

Submission : 2026-02-24

Status : Active

Type : IV

blank

08

Chongqing Bioland Pharmaceutical Ltd

Country

USDMF

arrow
Arvo
Not Confirmed

08

Chongqing Bioland Pharmaceutical Ltd

Country
arrow
Arvo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 40177

Submission : 2024-07-16

Status : Active

Type : IV

blank

09

Anhui Beirui Pharmaceutical Technolo...

Country

USDMF

arrow
Arvo
Not Confirmed

09

Anhui Beirui Pharmaceutical Technolo...

Country
arrow
Arvo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 40147

Submission : 2024-06-27

Status : Active

Type : IV

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

AOCS Annual Meeting
Not Confirmed
arrow
arrow
AOCS Annual Meeting
Not Confirmed

SALCAPROZATE SODIUM

NDC Package Code : 76339-179

Start Marketing Date : 2022-11-04

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (24.999kg/24.999kg)

Marketing Category : BULK INGREDIENT

blank

02

AOCS Annual Meeting
Not Confirmed
arrow
arrow
AOCS Annual Meeting
Not Confirmed

SALCAPROZATE SODIUM

NDC Package Code : 76339-505

Start Marketing Date : 2023-11-28

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (24.999kg/24.999kg)

Marketing Category : BULK INGREDIENT

blank

03

AOCS Annual Meeting
Not Confirmed
arrow
arrow
AOCS Annual Meeting
Not Confirmed

SALCAPROZATE SODIUM

NDC Package Code : 73212-066

Start Marketing Date : 2023-10-01

End Marketing Date : 2027-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank

04

AOCS Annual Meeting
Not Confirmed
arrow
arrow
AOCS Annual Meeting
Not Confirmed

SALCAPROZATE SODIUM

NDC Package Code : 42571-541

Start Marketing Date : 2025-06-12

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (10kg/10kg)

Marketing Category : BULK INGREDIENT

blank

05

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

SALCAPROZATE SODIUM

NDC Package Code : 71666-012

Start Marketing Date : 2021-03-19

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

06

Qingdao Qinzeyuan Biotechnology Co....

Country
AOCS Annual Meeting
Not Confirmed
arrow

Qingdao Qinzeyuan Biotechnology Co....

Country
arrow
AOCS Annual Meeting
Not Confirmed

SALCAPROZATE SODIUM

NDC Package Code : 85512-3037

Start Marketing Date : 2025-01-01

End Marketing Date : 2027-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

07

Hiray Pharma Solutions Ltd.

Country
AOCS Annual Meeting
Not Confirmed
arrow

Hiray Pharma Solutions Ltd.

Country
arrow
AOCS Annual Meeting
Not Confirmed

SALCAPROZATE SODIUM

NDC Package Code : 85203-000

Start Marketing Date : 2026-04-16

End Marketing Date : 2027-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

LGM Pharma

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

Salcaprozate Sodium

About the Company : LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product ...

LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product CDMO, offering formulation, analytical method development and testing, regulatory support, and commercial manufacturing. Supported by a network of over 220 accredited cGMP manufacturing partners and more than 100,000 sq. ft. of FDA-inspected cGMP manufacturing and warehouse space, LGM delivers secure, end-to-end solutions across multiple dosage forms. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
LGM Pharma CB

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAMI Lifesciences is Driven by Chemistry. Powered by People.

Flag India
Digital Content Digital Content

Salcaprozate Sodium

About the Company : Ami Lifesciences, established in 2006, is a rapidly growing API manufacturing company in India with strong capabilities in cardiovascular, anti-diabetic, CNS, and respiratory thera...

Ami Lifesciences, established in 2006, is a rapidly growing API manufacturing company in India with strong capabilities in cardiovascular, anti-diabetic, CNS, and respiratory therapies. The company offers a diverse portfolio of APIs, intermediates, key starting materials, and contract bulk manufacturing services. Its advanced manufacturing facilities in Gujarat and Karnataka feature dedicated clean rooms and comply with EU-GMP, WHO-GMP, PMDA, and COFEPRIS standards. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
AMI Lifesciences

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothZhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.

Flag China
Digital Content Digital Content

Salcaprozate Sodium

About the Company : Established in 2004 and headquartered in Hangzhou, Hengkang established multiple factories, research and sales centers in Zhejiang, Shandong, and Henan. With facilities conforming ...

Established in 2004 and headquartered in Hangzhou, Hengkang established multiple factories, research and sales centers in Zhejiang, Shandong, and Henan. With facilities conforming to global API standards, along with professional R&D and marketing teams, Hengkang’s operations span major pharmaceutical markets such as China, Europe, the CIS region, Japan, and South Korea. Hengkang has established long-term and stable relationships with nearly 70 countries overseas and hundreds of domestic enterprises. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Zhejiang Hengkang Pharmaceutical

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothShanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.

Flag China
Digital Content Digital Content

Salcaprozate Sodium

About the Company : Shanghai Minbiotech is specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square meters of R&D centers in...

Shanghai Minbiotech is specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square meters of R&D centers in Nantong, Jiangsu and Jinan, Shandong, with more than 13,000㎡ of production sites. While supplying products to customers, the company also provides services such as technology development, technology transfer and technology exchange, aiming to provide customers with comprehensive supply and solutions in the biomedical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Shanghai Minbiotech CB

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Flag India
Digital Content Digital Content

Salcaprozate Sodium

About the Company : Biophore, founded in 2007, develops and manufactures niche and complex pharmaceutical products. With USFDA- and EU-approved API facilities, a dedicated intermediates site and an R&...

Biophore, founded in 2007, develops and manufactures niche and complex pharmaceutical products. With USFDA- and EU-approved API facilities, a dedicated intermediates site and an R&D center of 400 scientists, the company is a leading global API player. Biophore ranks among the top US DMF filers, holds 150+ patents and maintains a strong compliance record with major regulatory agencies. Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Biophore

06

HRV Pharma

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content

Salcaprozate Sodium

About the Company : HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing...

HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing, manufacturing, and supply services to support partners entering new markets worldwide. HRV Pharma works closely with major pharma and food additive companies and represents over 30 Indian drugmakers, primarily serving Europe, the US, and the Middle East. Headquartered in India, it operates offices in the US, Switzerland, Dubai, Lithuania, and Turkey. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
HRV Global Life Sciences

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOmgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Flag India
Digital Content Digital Content

SNAC

About the Company : Omgene Life Sciences Pvt. Ltd. is an R&D-driven biopharmaceutical company specializing in biopharmaceuticals, peptides, semi-synthetic, and synthetic actives. As a vertically integ...

Omgene Life Sciences Pvt. Ltd. is an R&D-driven biopharmaceutical company specializing in biopharmaceuticals, peptides, semi-synthetic, and synthetic actives. As a vertically integrated company, we focus on developing high-quality formulations based on in-house-produced actives. With GMP-certified facilities and partnerships with contract manufacturers, we excel in formulation development for injectables, lyophilized injectables, complex generics, and oral peptide delivery systems, ensuring affordable, top-quality medicines. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Omgene Company Banner

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHonour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.

Flag India
Digital Content Digital Content

Salcaprozate Sodium

About the Company : Honour is a leading global CDMO and trusted manufacturer of specialty chemicals and ingredients, with seven world-class facilities meeting global safety and quality standards. Thro...

Honour is a leading global CDMO and trusted manufacturer of specialty chemicals and ingredients, with seven world-class facilities meeting global safety and quality standards. Through Honour Synthesis and Honour Specialty, it delivers innovative solutions leveraging chemistry expertise. Its team of over 2,500 professionals partners with pharmaceutical, biotech, and specialty industries worldwide to develop practical, scalable solutions. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWillow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

Flag U.S.A
Digital Content Digital Content

Salcaprozate Sodium

About the Company : Willow Birch Pharma, Inc. is a premier supplier of bulk APIs to North American Compounding Pharmacies, sourcing from FDA registered and GMP manufacturers. With licenses in all 50 s...

Willow Birch Pharma, Inc. is a premier supplier of bulk APIs to North American Compounding Pharmacies, sourcing from FDA registered and GMP manufacturers. With licenses in all 50 states as a drug wholesaler and NABP accreditation since 2007, Willow Birch Pharma delivers top-quality products at competitive prices with unparalleled service and regulatory support nationwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

10

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPanvo Organics: Advancing quality APIs and formulations with Halal, Kosher, US FDA, and WHO-approved manufacturing excellence.

Flag India
Digital Content Digital Content

Salcaprozate Sodium

About the Company : Panvo Organics Pvt. Ltd., established in 2006, is a WHO-GMP certified manufacturer of Active Pharmaceutical Ingredients, novel formulations, and sustainable agriculture inputs. The...

Panvo Organics Pvt. Ltd., established in 2006, is a WHO-GMP certified manufacturer of Active Pharmaceutical Ingredients, novel formulations, and sustainable agriculture inputs. The company operates a US FDA- and WHO-approved facility in Gummidipoondi and offers Halal- and Kosher-certified products. With an in-house R&D laboratory and pilot plant, Panvo Organics supports continuous innovation, advanced product development, and a growing intellectual property portfolio for global markets.Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Panvo Company Banner
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

LY3493269 is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.


Lead Product(s): LY3493269,Sodium Decanoate,Salcaprozate Sodium

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Undisclosed

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 03, 2023

blank

01

Eli Lilly

U.S.A
arrow
RDD
Not Confirmed

Eli Lilly

U.S.A
arrow
RDD
Not Confirmed

Details : LY3493269 is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Inapplicable

April 03, 2023

blank

Details:

NNC0385-0434 is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Renal Insufficiency, Chronic.


Lead Product(s): NNC0385-0434,Salcaprozate Sodium

Therapeutic Area: Nephrology Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Undisclosed

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 26, 2021

blank

02

Novo Nordisk

Denmark
arrow
RDD
Not Confirmed

Novo Nordisk

Denmark
arrow
RDD
Not Confirmed

Details : NNC0385-0434 is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Renal Insufficiency, Chronic.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Inapplicable

October 26, 2021

blank

Details:

NNC0385-0434 is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Atherosclerosis.


Lead Product(s): NNC0385-0434,Salcaprozate Sodium

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Undisclosed

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 05, 2021

blank

03

Novo Nordisk

Denmark
arrow
RDD
Not Confirmed

Novo Nordisk

Denmark
arrow
RDD
Not Confirmed

Details : NNC0385-0434 is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Atherosclerosis.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Inapplicable

August 05, 2021

blank

Details:

LY3493269 is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.


Lead Product(s): LY3493269,Salcaprozate Sodium

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Undisclosed

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 23, 2020

blank

04

Eli Lilly

U.S.A
arrow
RDD
Not Confirmed

Eli Lilly

U.S.A
arrow
RDD
Not Confirmed

Details : LY3493269 is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Inapplicable

December 23, 2020

blank

Details:

Furosemide is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Diabetes Mellitus.


Lead Product(s): Furosemide,Rosuvastatin Calcium,Salcaprozate Sodium,Semaglutide

Therapeutic Area: Endocrinology Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 05, 2017

blank

05

Novo Nordisk

Denmark
arrow
RDD
Not Confirmed

Novo Nordisk

Denmark
arrow
RDD
Not Confirmed

Details : Furosemide is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Diabetes Mellitus.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

January 05, 2017

blank

Details:

Semaglutide is a Peptide drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Diabetes Mellitus.


Lead Product(s): Semaglutide,Salcaprozate Sodium,Thyroxine

Therapeutic Area: Endocrinology Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Peptide, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 30, 2016

blank

06

Novo Nordisk

Denmark
arrow
RDD
Not Confirmed

Novo Nordisk

Denmark
arrow
RDD
Not Confirmed

Details : Semaglutide is a Peptide drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Diabetes Mellitus.

Product Name : Undisclosed

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

September 30, 2016

blank

Details:

SNAC is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.


Lead Product(s): Salcaprozate Sodium,Moxifloxacin

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 22, 2016

blank

07

Novo Nordisk

Denmark
arrow
RDD
Not Confirmed

Novo Nordisk

Denmark
arrow
RDD
Not Confirmed

Details : SNAC is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

September 22, 2016

blank

Details:

Semaglutide is a Peptide drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Diabetes Mellitus.


Lead Product(s): Semaglutide,Salcaprozate Sodium,Ethinyl Estradiol,Levonorgestrel

Therapeutic Area: Endocrinology Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Peptide, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 27, 2016

blank

08

Novo Nordisk

Denmark
arrow
RDD
Not Confirmed

Novo Nordisk

Denmark
arrow
RDD
Not Confirmed

Details : Semaglutide is a Peptide drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Diabetes Mellitus.

Product Name : Undisclosed

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

July 27, 2016

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Looking for 203787-91-1 / Salcaprozate Sodium API manufacturers, exporters & distributors?

Salcaprozate Sodium manufacturers, exporters & distributors 1

43

PharmaCompass offers a list of Salcaprozate Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Salcaprozate Sodium manufacturer or Salcaprozate Sodium supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Salcaprozate Sodium manufacturer or Salcaprozate Sodium supplier.

API | Excipient name

Salcaprozate Sodium

Synonyms

203787-91-1, Snac, Sodium 8-(2-hydroxybenzamido)octanoate, E414, Salcaprozate sodium [usan], Sodium;8-[(2-hydroxybenzoyl)amino]octanoate

Cas Number

203787-91-1

Unique Ingredient Identifier (UNII)

1YTW0422YU

About Salcaprozate Sodium

Salcaprozate Sodium is the sodium salt form of salcaprozate, an oral absorption promoter. Salcaprozate sodium may be used as a delivery agent to promote the oral absorption of certain macromolecules with poor bioavailability such as insulin and heparin.

Salcaprozate Sodium Manufacturers

A Salcaprozate Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Salcaprozate Sodium, including repackagers and relabelers. The FDA regulates Salcaprozate Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Salcaprozate Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Salcaprozate Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Salcaprozate Sodium Suppliers

A Salcaprozate Sodium supplier is an individual or a company that provides Salcaprozate Sodium active pharmaceutical ingredient (API) or Salcaprozate Sodium finished formulations upon request. The Salcaprozate Sodium suppliers may include Salcaprozate Sodium API manufacturers, exporters, distributors and traders.

click here to find a list of Salcaprozate Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Salcaprozate Sodium USDMF

A Salcaprozate Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Salcaprozate Sodium active pharmaceutical ingredient (API) in detail. Different forms of Salcaprozate Sodium DMFs exist exist since differing nations have different regulations, such as Salcaprozate Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Salcaprozate Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Salcaprozate Sodium USDMF includes data on Salcaprozate Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Salcaprozate Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Salcaprozate Sodium suppliers with USDMF on PharmaCompass.

Salcaprozate Sodium WC

A Salcaprozate Sodium written confirmation (Salcaprozate Sodium WC) is an official document issued by a regulatory agency to a Salcaprozate Sodium manufacturer, verifying that the manufacturing facility of a Salcaprozate Sodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Salcaprozate Sodium APIs or Salcaprozate Sodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Salcaprozate Sodium WC (written confirmation) as part of the regulatory process.

click here to find a list of Salcaprozate Sodium suppliers with Written Confirmation (WC) on PharmaCompass.

Salcaprozate Sodium NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Salcaprozate Sodium as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Salcaprozate Sodium API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Salcaprozate Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Salcaprozate Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Salcaprozate Sodium NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Salcaprozate Sodium suppliers with NDC on PharmaCompass.

Salcaprozate Sodium GMP

Salcaprozate Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Salcaprozate Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Salcaprozate Sodium GMP manufacturer or Salcaprozate Sodium GMP API supplier for your needs.

Salcaprozate Sodium CoA

A Salcaprozate Sodium CoA (Certificate of Analysis) is a formal document that attests to Salcaprozate Sodium's compliance with Salcaprozate Sodium specifications and serves as a tool for batch-level quality control.

Salcaprozate Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Salcaprozate Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Salcaprozate Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Salcaprozate Sodium EP), Salcaprozate Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Salcaprozate Sodium USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty